reference/29398154

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/29398154

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Controlled Clinical Trial\|Journal Article
endingPage	2332
issn	1524-4628 0039-2499
issueIdentifier	10
pageRange	2328-2332
publicationName	Stroke
startingPage	2328
bibliographicCitation	Kapadia SR, Bajzer CT, Ziada KM, Bhatt DL, Wazni OM, Silver MJ, Beven EG, Ouriel K, Yadav JS. Initial experience of platelet glycoprotein IIb/IIIa inhibition with abciximab during carotid stenting: a safe and effective adjunctive therapy. Stroke. 2001 Oct;32(10):2328–32. doi: 10.1161/hs1001.096003. PMID: 11588321.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d0f01989340699aa700275bbd355c0b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f9f41fdd437a209df70627756bf87c1b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_567c348de1d03c063124d0784ff15e65 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6dfb230a15362c358048f245417c5d74 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ac574575ff50d714110eb332f68ecdd3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b12fcb2d0177bf5680c0d3a84e7bfe1a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c55cd81049b04e483e6976e6fd6cd287 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d35f11c907064da3ee3ab4049c04d99b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d51b266340cc66691c9c2a2b3a76eb24
date	200110
identifier	https://doi.org/10.1161/hs1001.096003 https://pubmed.ncbi.nlm.nih.gov/11588321
isPartOf	https://portal.issn.org/resource/ISSN/1524-4628 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/7613 https://portal.issn.org/resource/ISSN/0039-2499
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Initial experience of platelet glycoprotein IIb/IIIa inhibition with abciximab during carotid stenting: a safe and effective adjunctive therapy
discusses	http://id.nlm.nih.gov/mesh/M0011126 http://id.nlm.nih.gov/mesh/M0017012 http://id.nlm.nih.gov/mesh/M0000432 http://id.nlm.nih.gov/mesh/M0227707 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0022396 http://id.nlm.nih.gov/mesh/M0028424
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D015607Q000009 http://id.nlm.nih.gov/mesh/D019039Q000037 http://id.nlm.nih.gov/mesh/D002340Q000601 http://id.nlm.nih.gov/mesh/D000911Q000627 http://id.nlm.nih.gov/mesh/D007140Q000627 http://id.nlm.nih.gov/mesh/D019917Q000009 http://id.nlm.nih.gov/mesh/D013923Q000517
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006083Q000517 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D013923Q000209 http://id.nlm.nih.gov/mesh/D012307 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D018570 http://id.nlm.nih.gov/mesh/D000077284 http://id.nlm.nih.gov/mesh/D000911Q000009 http://id.nlm.nih.gov/mesh/D000277Q000627 http://id.nlm.nih.gov/mesh/D020300Q000209 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D014568Q000627 http://id.nlm.nih.gov/mesh/D006083Q000209 http://id.nlm.nih.gov/mesh/D010975Q000627 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D007140Q000009
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8166 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_77f2a7aa26c2bfc427c7b9e127e4fda9 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10545 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID638015 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8198 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12210218 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7218 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128684338

Total number of triples: 71.